Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Safety and efficacy of up to 76 weeks 10 mg/day (high dose) bulevirtide monotherapy in compensated cirrhotics with delta hepatitis

A. Loglio,P. Ferenci, F. Schlund, C.Y.L. Tham,F. van Bömmel, Sc. Uceda Renteria,M. Borghi,H. Holzmann,R. Perbellini,E. Trombetta,S. Giovanelli,L. Porretti,D. Prati,F. Ceriotti,G. Lunghi,A. Bertoletti,S. Urban,P. Lampertico

Digestive and Liver Disease（2020）

Cited 2|Views45
No score
Abstract
Introduction: Treatment with Bulevirtide (BLV) 10 mg/day + TDF is effective in HDV hepatitis in 48-weeks clinical trial.
More
Translated text
Key words
bulevirtide monotherapy,high dose,cirrhotics
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined